“Diseases caused by parasites have plagued humankind for millennia and constitute a major global health problem. In particular, parasitic diseases affect the world’s poorest populations and represent a huge barrier to improving human health and wellbeing. This year’s Nobel Laureates have developed therapies that have revolutionized the treatment of some of the most devastating parasitic diseases.
William C. Campbell and Satoshi Ōmura discovered a new drug, Avermectin, the derivatives of which have radically lowered the incidence of River Blindness and Lymphatic Filariasis, as well as showing efficacy against an expanding number of other parasitic diseases…
Today the Avermectin-derivative Ivermectin is used in all parts of the world that are plagued by parasitic diseases. Ivermectin is highly effective against a range of parasites, has limited side effects and is freely available across the globe. The importance of Ivermectin for improving the health and wellbeing of millions of individuals with River Blindness and Lymphatic Filariasis, primarily in the poorest regions of the world, is immeasurable. Treatment is so successful that these diseases are on the verge of eradication, which would be a major feat in the medical history of humankind…
The global impact of their discoveries and the resulting benefit to mankind are immeasurable.”
Subject specifically to the rights of third parties (which are entirely the responsibility of the user), Nobel Prize Outreach consents to the reproduction, distribution, display, transmission, performance, and use of the Content by individual teachers and other educators if done for the limited purpose of classroom or workshop instruction (including online intranet instruction) in a school or other educational organization; provided, however, said organization is a not-for-profit legal entity and provided, further, that the Content and compilation are not sold or otherwise commercially distributed. Unless otherwise noted on the Site, Nobel Prize Outreach requires no express permission for a limited educational exemption, but to conditions apply: No modifications may be made as to the integrity or attribution of the Content; and All copies of the Content must bear accurate identifying information, including proprietary collection information, credit lines, copyright (©), including relevant year if appropriate, and trademark notices (® or TM), and a citation of the Site: https://www.nobelprize.org.